Literature DB >> 9186600

The PDAY Study: natural history, risk factors, and pathobiology. Pathobiological Determinants of Atherosclerosis in Youth.

J P Strong1, G T Malcom, M C Oalmann, R W Wissler.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9186600     DOI： 10.1111/j.1749-6632.1997.tb52004.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  14 in total

1.  Peak oxygen uptake, ventilatory threshold, and arterial stiffness in adolescents.

Authors:  Eero A Haapala; Jari A Laukkanen; Tim Takken; Urho M Kujala; Taija Finni
Journal:  Eur J Appl Physiol       Date:  2018-08-11       Impact factor: 3.078

2.  Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis?

Authors:  Xiaohua Song; Qi Ma; Xialin Liu; Pearl Seo; Ed Herderick; Keith Webster; Pascal J Goldschmidt-Clermont; David Seo
Journal:  Antioxid Redox Signal       Date:  2011-09-22       Impact factor: 8.401

3.  New cholesterol guidelines: worth the wait?

Authors:  Chad Raymond; Leslie Cho; Michael Rocco; Stanley L Hazen
Journal:  Cleve Clin J Med       Date:  2014-01       Impact factor: 2.321

4.  Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice.

Authors:  Jinghua Bie; Bin Zhao; Shobha Ghosh
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-07-27       Impact factor: 3.619

5.  Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells.

Authors:  Redouane Aherrahrou; Liang Guo; V Peter Nagraj; Aaron Aguhob; Jameson Hinkle; Lisa Chen; Joon Yuhl Soh; Dillon Lue; Gabriel F Alencar; Arjan Boltjes; Sander W van der Laan; Emily Farber; Daniela Fuller; Rita Anane-Wae; Ngozi Akingbesote; Ani W Manichaikul; Lijiang Ma; Minna U Kaikkonen; Johan L M Björkegren; Suna Önengüt-Gümüşcü; Gerard Pasterkamp; Clint L Miller; Gary K Owens; Aloke Finn; Mohamad Navab; Alan M Fogelman; Judith A Berliner; Mete Civelek
Journal:  Circ Res       Date:  2020-10-12       Impact factor: 17.367

Review 6.  Acute coronary syndromes in black Americans: is treatment different? Should it be?

Authors:  Luther T Clark; Umesh Lingegowda
Journal:  Curr Cardiol Rep       Date:  2005-07       Impact factor: 2.931

7.  Engineering nanomaterials to address cell-mediated inflammation in atherosclerosis.

Authors:  Sean Allen; Yu-Gang Liu; Evan Scott
Journal:  Regen Eng Transl Med       Date:  2016-03-03

Review 8.  Contemporary treatment of heart failure: is there adequate evidence to support a unique strategy for African-Americans? Con position.

Authors:  Keith C Ferdinand; Claudia C Serrano; Daphne P Ferdinand
Journal:  Curr Hypertens Rep       Date:  2002-08       Impact factor: 5.369

9.  Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.

Authors:  Jill C Rau; Carolyn Deans; Maureane R Hoffman; David B Thomas; Gray T Malcom; Arthur W Zieske; Jack P Strong; Gary G Koch; Frank C Church
Journal:  Exp Mol Pathol       Date:  2009-09-09       Impact factor: 3.362

10.  Dyslipidemia in Iranian overweight and obese children.

Authors:  Robabeh Ghergerehchi
Journal:  Ther Clin Risk Manag       Date:  2009-09-24       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.